Title : Molecular diagnostics in critically Ill patients with severe pneumonia
Abstract:
Severe pneumonia is one of the most common causes of sepsis and respiratory failure requiring intensive care. Despite advances in diagnostic techniques, antimicrobial therapy, respiratory support and organ support modalities; mortality and morbidity of severe pneumonia remain significantly high. In this session, epidemiology of severe community acquired pneumonia and hospital acquired pneumonia will be discussed. Current challenges in management of severe pneumonia will be highlighted. A broad overview of current and emergency molecular and syndromic testing for severe pneumonia will be provided including a discussion of advantages and limitations of such technique. A summary of current research into molecular diagnostics in severe pneumonia will be provided and future research directions will be explored.
Audience take away:
? Epidemiology of severe community acquired and hospital acquired pneumonia requiring intensive care
? Current challenges in the management of severe pneumonia in the ICU
? Benefits and limitations of molecular diagnostics in the management of severe pneumonia
? Current and future research directions